CLINICAL_TRIALS
trial_result
· 2009-06-25
Clinical Trial Update: Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis [Phase 1, Phase 2]
Summary
Early bactericidal activity data for multiple drugs (linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin) in HIV-negative adults with initial sputum …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2009-06-25